Centene Corp

Latest Results (24.10.2025):

Centene Corporation reported its second-quarter financial results for 2025, showing a diluted loss per share of $(0.51) and adjusted diluted loss per share of $(0.16). Total revenues reached $48.7 billion, driven by significant growth in premium and service revenues. Despite the challenges, Centene remains focused on strengthening its platform and delivering long-term value to its stakeholders.

Revenue Growth

Premium and service revenues increased by 18% to $42.5 billion in the second quarter of 2025 compared to $36.0 billion in the same period last year. The growth was primarily fueled by the PDP business and market expansion in the Marketplace sector.

Operating Efficiency

The SG&A expense ratio improved to 7.1% from 8.0% year-over-year, reflecting better expense management and higher revenues. This enhancement was partly due to the expansion of the PDP business, which operates with a more favorable expense ratio.

Membership Expansion

Total at-risk membership grew to 28.0 million by June 30, 2025, up from 25.7 million in the previous year. Notable increases were observed in the Marketplace and Commercial segments, contributing to the overall membership growth.

Cash Flow and Balance Sheet

Cash flow from operations reached $1.8 billion, supported by improved pharmacy rebate remittance timing. The company maintained a strong balance sheet with $37.5 billion in cash, investments, and restricted deposits, and total debt stood at $17.6 billion.

Outlook and Strategic Focus

Despite the second-quarter losses, Centene's CEO emphasized a clear strategy to restore earnings trajectory. The company is committed to adapting to market changes and leveraging the enduring strength of Medicaid, Medicare, and the Individual Marketplace to deliver long-term value.